Research Article
Transcatheter Mitral Valve Replacement in High-Surgical Risk Patients: A Single-Center Experience and Outcome
Table 3
Echocardiographic assessments of valvular function throughout follow-up.
| | TMVR total N: 64 | Groups | -value | TMViV N: 35 (55%) | TMViR N: 16 (25%) | TMViMAC N: 13 (20%) |
| MV mean Pg (mmHg) | Preprocedure | 14.3 ± 5.3 | 14.8 ± 5.1 | 12.1 ± 4.6 | 15.5 ± 6.4 | 0.162 | Immediately/In-hospital | 4.4 ± 1.2 | 4.2 ± 1.3 | 4.4 ± 1.0 | 4.6 ± 1.0 | 0.618 | <0.001 | <0.001 | <0.001 | <0.001 | 3-month postprocedure | 4.7 ± 1.3 | 4.9 ± 1.4 | 4.6 ± 1.0 | 5.1 ± 1.4 | 0.554 | <0.001 | <0.001 | <0.001 | <0.001 | 6-month postprocedure | 5.4 ± 1.6 | 4.9 ± 1.7 | 5.4 ± 1.5 | 5.5 ± 1.4 | 0.438 | <0.001 | <0.001 | <0.001 | <0.001 |
| MR | Preprocedure | | | | | 0.319 | (i) Trivial/Mild | 3 (4.7%) | 3 (8.6%) | 0 (0.0%) | 0 (0.0%) | (ii) Moderate | 15 (23.4%) | 8 (22.7%) | 5 (31.3%) | 2 (15.4%) | (iii) Sever | 26 (40.6%) | 10 (28.6%) | 7 (43.8%) | 9 (69.2%) | Immediately/In-hospital (Trivial/Mild) | 10 (15.6%) | 3 (8.6%) | 5 (31.3%) | 2 (15.4%) | 0.215 | <0.001 | <0.001 | <0.001 | 0.001 | 3-month postprocedure (trivial/mild/moderate) | 11 (17.2%) | 3 (8.6%) | 6 (37.5%) | 2 (15.4%) | 0.074 | <0.001 | <0.001 | <0.001 | 0.002 | 6-month postprocedure (trivial/mild/moderate) | 17 (26.6%) | 9 (25.7%) | 6 (37.5%) | 2 (15.4%) | 0.670 | <0.001 | <0.001 | <0.001 | 0.002 |
| LVEF (%) | Preprocedure | 48.8 ± 15.8 | 49.3 ± 13.8 | 34.4 ± 11.4 | 65.2 ± 5.8 | <0.001 | Immediately/In-hospital | 50.7 ± 14.8 | 51.6 ± 12.9 | 36.8 ± 10.7 | 65.5 ± 5.9 | <0.001 | <0.001 | <0.001 | 0.006 | 0.610 | 3-month postprocedure | 52.3 ± 14.0 | 52.7 ± 12.2 | 40.3 ± 11.8 | 65.8 ± 62 | <0.001 | <0.001 | <0.001 | <0.001 | 0.292 | 6-month postprocedure | 53.8 ± 13.0 | 54.6 ± 11.1 | 42.4 ± 11.9 | 65.9 ± 5.6 | <0.001 | <0.001 | <0.001 | <0.001 | 0.157 |
| ESPAP (mm Hg) | Pre-procedure | 67.9 ± 18.8 | 69.7 ± 19.3 | 61.6 ± 20.4 | 70.8 ± 14.6 | 0.302 | Immediately/In-hospital | 61.0 ± 15.4 | 60.5 ± 14.3 | 56.6 ± 17.4 | 67.5 ± 14.3 | 0.05 | <0.001 | <0.001 | 0.038 | 0.072 | 3-month postprocedure | 55.0 ± 15.1 | 52.6 ± 12.7 | 50.8 ± 16.7 | 66.5 ± 14.6 | 0.006 | <0.001 | <0.001 | 0.002 | 0.063 | 6-month postprocedure | 51.7 ± 13.6 | 48.8 ± 9.8 | 47.7 ± 14.6 | 66.0 ± 14.7 | 0.001 | <0.001 | <0.001 | 0.001 | 0.059 |
| LVOT Pg (mmHg) | Pre-procedure | 3.14 ± 1.8 | 2.7 ± 1.8 | 2.7 ± 1.3 | 4.9 ± 0.9 | <0.001 | Immediately/In-hospital | 4.0 ± 1.8 | 3.0 ± 1.4 | 3.6 ± 1.5 | 6.1 ± 0.8 | <0.001 | <0.001 | 0.086 | 0.59 | <0.001 | 3-month postprocedure | 4.1 ± 1.9 | 3.1 ± 1.4 | 3.9 ± 1.3 | 6.45 ± 1.1 | <0.001 | <0.001 | 0.055 | 0.057 | <0.001 | 6-month postprocedure | 4.4 ± 2.2 | 3.1 ± 1.5 | 4.0 ± 1.3 | 7.5 ± 1.9 | <0.001 | <0.001 | 0.061 | 0.053 | <0.001 |
|
|
ESPAP: estimated systolic pulmonary artery pressure, LVEF: left ventricular ejection fraction, LVOT: left ventricular outflow tract, MR: mitral regurgitation, MV: mitral valve, Pg: pressure gradient, TMVR: transcatheter mitral valve replacement, TMViV: transcatheter mitral valve-in-valve, TMViR: transcatheter mitral valve-in-ring, TMViMAC: transcatheter mitral valve-in-mitral annular calcification.
|